Developed by Visible Genetics Inc., the TRUGENE™ HIV-1 Genotyping Kit and the OpenGene™ DNA Sequencing System represents the first DNA sequence-based pharmacogenomics test cleared by the FDA.
This “integrated system” is comprised of the chemistry, hardware, software and interpretative patient report necessary to generate test results as well as system training, certification and service.
The TRUGENE HIV-1 test analyzes the genetic profile of the HIV-1 virus and generates the TRUGENE HIV-1 Resistance Report. This easy-to-understand report provides information to the physician about which antiretroviral drugs are likely to be effective in treating the HIV infection of an individual patient.